Puredutide + Cagrilintide (a Tirzepatide + Cagrilintide analogue)

Dhs. 1,770.00 AED

10 left

Puredutide + Cagrilintide is a combination of two molecules in a single syringe pen, studied in the context of appetite regulation and metabolism. Puredutide is associated with the incretin pathway, while cagrilintide acts as an amylin analogue.

3 mL cartridge with 300 clicks (syringe pen format, 50/5 mg):

Puredutide — 50 mg
Cagrilintide — 5 mg

One click delivers approximately 0.01 mL, containing 0.167 mg of Puredutide and 0.017 mg of Cagrilintide.

In experimental models, GLP-1 agonism is investigated in relation to appetite signaling and insulin and glucagon levels. GIP agonism is studied in connection with glucose metabolism and lipolysis under conditions of hyperinsulinemia.

For the amylin analogue, research examines activation of the relevant receptors and associated measures of satiety, gastric emptying, meal frequency, and calorie intake.

For the combination, changes in hunger, blood glucose levels, lipolysis, and eating behavior are considered research endpoints rather than established effects in humans.

The combination of a dual incretin receptor agonist and an amylin component is being investigated in the context of appetite regulation, glycemic control, and eating behavior. This material is intended exclusively for research and professional use.

Syringe pen with a 3 mL cartridge containing 300 clicks (50/5 mg). Please contact our manager to confirm availability. Certificates of conformity are available for the product.

We deliver throughout Dubai. Once you place your order, our manager will contact you to confirm product availability. Payment is due after your order has been confirmed.

HPLC-Verified Purity (≥98%)

Temperature-Safe Delivery

24-Month
Shelf Life

Free Dubai
Delivery

FAQ

Puredutide is described as a genetically engineered hybrid molecule. In laboratory models, researchers investigate its ability to reproduce food-related signaling responses through activation of GLP-1 and GIP receptors. Cagrilintide is a synthetic amylin analogue studied in relation to satiety signaling and gastric motility.

The combination is being investigated in the context of interactions between three signaling pathways, including pancreatic signaling, appetite-regulating centers in the hypothalamus, and gastrointestinal motility.